|
|
Volumn 173, Issue 5, 2000, Pages 341-345
|
|
Migraine prophylaxis in adult patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMITRIPTYLINE;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
DOXEPIN;
FENOPROFEN;
FLUNARIZINE;
FLURBIPROFEN;
IMIPRAMINE;
KETOPROFEN;
LISURIDE;
MEFENAMIC ACID;
METHYSERGIDE;
METOPROLOL;
NADOLOL;
NAPROXEN;
NIFEDIPINE;
NIMODIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORTRIPTYLINE;
PHENELZINE;
PINDOLOL;
PIZOTIFEN;
PROPRANOLOL;
PROTRIPTYLINE;
TIMOLOL MALEATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROATE SEMISODIUM;
VALPROIC ACID;
VERAPAMIL;
ANTICHOLINERGIC EFFECT;
BRADYCARDIA;
BRONCHOSPASM;
DOSE RESPONSE;
DRUG EFFICACY;
FATIGUE;
HAIR LOSS;
HEADACHE;
HUMAN;
HYPOTENSION;
IMPOTENCE;
MIGRAINE;
NAUSEA;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PROPHYLAXIS;
QUALITY OF LIFE;
REVIEW;
RISK BENEFIT ANALYSIS;
SEDATION;
TREMOR;
VERTIGO;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CALCIUM CHANNEL BLOCKERS;
HUMANS;
MIGRAINE DISORDERS;
|
|
EID: 0033666083
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: 10.1136/ewjm.173.5.341 Document Type: Review |
|
Times cited : (11)
|
|
References (32)
|
